We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Immunity to COVID-19 Higher Than Serological Tests Suggest

By HospiMedica International staff writers
Posted on 06 Jul 2020
A new study shows that many people with mild or asymptomatic COVID-19 demonstrate a T-cell-mediated immunity, even if they have not tested positively for antibodies. More...


For the study, researchers at Karolinska Institutet (Solna, Sweden) and Karolinska University Hospital (KUH; Stockholm, Sweden) performed immunological analyses of samples from over 200 inpatients (many of whom had mild or no symptoms of COVID-19) at KUH, as well as their exposed asymptomatic family members who returned to Stockholm after holidaying in the Alps in March 2020. Healthy blood donors who gave blood during 2020 and 2019 (the control group) were also included.

The researchers then mapped the functional and phenotypic landscape of T-cell responses. They found that SARS-CoV-2-specific T cells were detectable in seronegative family members and individuals with a history of asymptomatic or mild COVID-19. The collective dataset showed that SARS-CoV-2 elicits robust memory T cell responses, akin to those observed in the context of successful vaccines, suggesting that natural exposure or infection may prevent recurrent episodes of severe COVID-19 in seronegative individuals as well. The study was published on June 29, 2020, in in bioRxiv.

“T cells are a type of white blood cells that are specialized in recognizing virus-infected cells, and are an essential part of the immune system. Advanced analyses have now enabled us to map in detail the T-cell response during and after a COVID-19 infection,” said senior author Marcus Buggert, PhD, of KI. “Our results indicate that roughly twice as many people have developed T-cell immunity compared with those who we can detect antibodies in.”

“One interesting observation was that it wasn't just individuals with verified COVID-19 who showed T-cell immunity, but also many of their exposed asymptomatic family members,” said study co-author Soo Aleman, PhD, of KUH. “Moreover, roughly thirty percent of the blood donors who'd given blood in May 2020 had COVID-19-specific T cells, a figure that's much higher than previous antibody tests have shown.”

T cells are lymphocytes that originate in the bone marrow and mature in the thymus. They determine the specificity of immune response to antigens. They can be distinguished from other lymphocytes by the presence of a T-cell receptor on the cell surface. One of the more important T-cells are CD4+ helper cells which send signals to other types of immune cells, including CD8 killer cells, which then destroy the infectious particle.

Related Links:
Karolinska Institutet
Karolinska University Hospital



Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Radiofrequency Generator
GX1
Surgical System
Stealth AXiS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.